RecruitingNCT07343167
Factors Associated With Mortality in Streptococcal Anginosus Bacteremia
Sponsor
University Hospital, Strasbourg, France
Enrollment
400 participants
Start Date
Sep 8, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Streptococcal anginosus infections (S. constellatus, S. anginosus, and S. intermedius) are characterized by their severity, linked to high mortality and frequent infectious complications. Several studies in the literature highlight this severity, with mortality rates estimated at around 15%. The aim of this research is to identify the factors associated with mortality in Streptococcal anginosus bacteremia.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Major subject (≥18 years old)
- Hospitalized between January 1, 2019, and December 31, 2024, in one of the participating centers
- Having presented during the study period at least one positive blood culture for Streptococcus anginosus, Streptococcus constellatus, or Streptococcus intermedius in a laboratory at a participating center
Exclusion Criteria1
- Refusal to participate in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07343167
Related Trials
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
NCT070177773 locations
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
NCT070857022 locations